862
Participants
Start Date
July 31, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Symbicort (Budesonide/Formoterol)
Turbuhaler 160/4.5 µg delivered dose, twice daily (one inhalation in the morning and one inhalation in the evening) and as need (prn) in response to symptoms
Research Site, Guangzhou
Research Site, Zheng Ahou
Research Site, Wuhan
Research Site, Changsha
Research Site, Qingdao
Research Site, Shanghai
Research Site, Beijing
Research Site, Chengdu
Research Site, Fuzhou
Research Site, Hangzhou
Research Site, Nanjing
Research Site, Shenyang
Research Site, Zhengzhou
Research Site, Hyderabad
Research Site, Ahmedabad
Research Site, Bangalore
Research Site, Bengaluru
Research Site, Indore
Research Site, Mumbai
Research Site, Chennai
Research Site, Coimbatore
Research Site, Lucknow
Research Site, Noida
Research Site, Jakarta
Research Site, Surabaya
Research Site, Chiayi City
Research Site, Kaohsiung City
Research Site, Taichung
Research Site, Taipei
Research Site, Taoyuan
Research Site, Taoyuan District
Research Site, Bangkok
Research Site, Pathumwan
Research Site, Pathum Thani
Research Site, Nakhonratchasima
Lead Sponsor
AstraZeneca
INDUSTRY